Life Sciences Ulysses Dashboard

Dedalus Consulting Ulysses Dashboard for Life Sciences are interactive subscription dashboards with 24/7 access to continuously updated data. The Life Sciences coverage tracks the microfabricated devices used in diagnostics, drug discovery, and medical research, with historical data and forecasts from 2000 through 2040.

Markets covered

• BioChips and BioMEMS (lab-on-a-chip, biosensors, microfluidics, drug delivery)

How the data is segmented

Data is broken down by product type, country and region, end-user industry, and, where relevant, grade and distribution channel. Figures include market value (US$ millions), growth rates (CAGR), and market shares of leading producers.

Key facts

• Publisher: Dedalus Consulting, 30 Wall Street, New York, NY (founded 2002)
• Coverage period: 2000–2040 (historical data and forecasts)
• Geography: Global, with country-level data for the Americas, Europe, Asia/Pacific, the Middle East, and Africa
• Method: Primary interviews with producers and end-users, proprietary shipment models, and a continuous time series maintained for more than 20 years
• Format: Online dashboard subscription with data from 2004 through 2040

Frequently asked questions

What does the Life Sciences Ulysses Dashboard series include?
The series covers BioChips and BioMEMS. Each title provides always-current data in interactive dashboards, with 24/7 access and regular updates.

Who uses this research?
Typical buyers are medical device makers, diagnostics companies, research institutions, and investors, as well as strategy consultancies and investment banks conducting market due diligence.

How is Dedalus data different from other market research?
Dedalus figures come from primary research with producers, not desk estimates, and are broken down to the product-subtype and country level. The methodology has been used in institutional investor due diligence.

Suggested citation: Dedalus Consulting, Life Sciences: Ulysses Dashboard (2026), dedalusconsulting.com.